NEW YORK (GenomeWeb) – Nearly 20 percent of men with prostate cancer harbor a germline variant that places them at increased risk of developing the disease, according to a new study, but a third of them were not eligible for genetic testing according to guidelines in place at the time.
To read the full story....
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.